The present invention relates to compounds of the following general formula (I) or (II): or a pharmaceutically acceptable salt and/or solvate thereof, for use in the treatment and/or in the prevention of ErbB2 dependent cancers, and pharmaceutical compositions containing such compounds. ##STR00001##

The present invention relates to compounds of the following general formula (I) or (II): or a pharmaceutically acceptable salt and/or solvate thereof, for use in the treatment and/or in the prevention of ErbB2 dependent cancers, and pharmaceutical compositions containing such compounds. ##STR00001##

Described are polymerizable high energy light absorbing compounds. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.

The present invention relates to compounds of the following general formula (I) or (II): or a pharmaceutically acceptable salt and/or solvate thereof, for use in the treatment and/or in the prevention of ErbB2 dependent cancers, and pharmaceutical compositions containing such compounds.

##STR00001##

The present invention relates to compounds of the following general formula (I) or (II): or a pharmaceutically acceptable salt and/or solvate thereof, for use in the treatment and/or in the prevention of ErbB2 dependent cancers, and pharmaceutical compositions containing such compounds.

##STR00001##

Described are a compound of formula (II) or (III):

##STR00001##

The compounds are effective in the treatment of disease, including a tauopathy condition or a disease of tau protein aggregation.

Described are a compound of formula (II) or (III): ##STR00001## The compounds are effective in the treatment of disease, including a tauopathy condition or a disease of tau protein aggregation.

A light-emitting device includes a first electrode, a second electrode facing the first electrode, and an interlayer including an emission layer between the first electrode and the second electrode and a hole transport region between the first electrode and the emission layer, wherein the emission layer may include a dopant, the hole transport region may include a first hole transport layer, a second hole transport layer between the first hole transport layer and the emission layer, and a third hole transport layer between the second hole transport layer and the emission layer, the first hole transport layer may include a first compound, the second hole transport layer may include a second compound, the third hole transport layer may include a third compound, and the first to third compounds may each independently be an amine-based compound, but may be different from each other.

A light-emitting device includes a first electrode, a second electrode facing the first electrode, and an interlayer including an emission layer between the first electrode and the second electrode and a hole transport region between the first electrode and the emission layer, wherein the emission layer may include a dopant, the hole transport region may include a first hole transport layer, a second hole transport layer between the first hole transport layer and the emission layer, and a third hole transport layer between the second hole transport layer and the emission layer, the first hole transport layer may include a first compound, the second hole transport layer may include a second compound, the third hole transport layer may include a third compound, and the first to third compounds may each independently be an amine-based compound, but may be different from each other.

Described are polymerizable fused tricyclic compounds of formula I: ##STR00001##
wherein R.sup.1, R.sup.2, R.sup.3, m, n, t, and rings B, C, and D are as defined herein. The compounds absorb various wavelengths of ultraviolet and/or visible light (such as high energy visible light) and are suitable for incorporation in a variety of products, such as biomedical devices and ophthalmic devices.